Introduction The purpose of the study was to comprehensively evaluate physiologic changes associated with development of high altitude pulmonary edema (HAPE). We tested whether changes in pulmonary function and breathing pattern would herald clinically overt HAPE at an early stage. Methods In 18 mountaineers, spirometry, diffusing capacity, nitrogen washout, nocturnal ventilation and pulse oximetry were recorded at 490 m and during 3 days after rapid ascent to 4559 m. Findings were compared among subjects developing HAPE and those remaining well (controls). Results In 8 subjects subsequently developing radiographically documented HAPE at 4559 m, median FVC declined to 82% of low altitude baseline while closing volume increased to 164% of baseline (P<0.05, both instances). In 10 controls, FVC decreased slightly (to 93% baseline, P<0.05) but significantly less than in subjects with HAPE and closing volume remained unchanged. Sniff nasal pressure was reduced in both subjects with and without subsequent HAPE. During nights at 4559 m, mean nocturnal oxygen saturation dropped to lower values while minute ventilation, the number of periodic breathing cycles and heart rate were higher (60%; 8.6 L/min; 97 cycles/h; 94 beats/min, respectively) in subjects subsequently developing HAPE than in controls (73%; 5.1 L/min; 48 cycles/h; 79 beats/min; P<0.05 vs. HAPE, all instances). Conclusion The results comprehensively represent the pattern of physiologic alterations that precede overt HAPE. The changes in lung function are consistent with reduced lung compliance and impaired gas exchange. Pronounced nocturnal hypoxemia, ventilatory control instability and sympathetic stimulation are further signs of subsequent overt HAPE. Registration ClinicalTrials.gov identifier: NCT00274430
References
[1]
Cremona G, Asnaghi R, Baderna P, Brunetto A, Brutsaert T, et al. (2002) Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study. Lancet 359: 303–309.
[2]
Senn O, Clarenbach CF, Fischler M, Thalmann R, Brunner-La Rocca H, et al. (2006) Do changes in lung function predict high-altitude pulmonary edema at an early stage? Med Sci Sports Exerc 38: 1565–1570.
[3]
Dehnert C, Luks AM, Schendler G, Menold E, Berger MM, et al. (2010) No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559 m. Eur Respir J 35: 812–820.
[4]
Eichenberger U, Weiss E, Riemann D, Oelz O, Bartsch P (1996) Nocturnal periodic breathing and the development of acute high altitude illness. Am J Respir Crit Care Med 154: 1748–1754.
[5]
Maggiorini M, Brunner-La Rocca HP, Peth S, Fischler M, Bohm T, et al. (2006) Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 145: 497–506.
[6]
Lehmann T, Mairbaurl H, Pleisch B, Maggiorini M, Bartsch P, et al. (2006) Platelet count and function at high altitude and in high-altitude pulmonary edema. J Appl Physiol 100: 690–694.
[7]
Maggiorini M, Muller A, Hofstetter D, Bartsch P, Oelz O (1998) Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat Space Environ Med 69: 1186–1192.
[8]
Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, et al. (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26 511–522: 26/3/511.
[9]
MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, et al. (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26: 720–735.
[10]
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, et al. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. pp. 5–40.
[11]
American Thoracic Society (2002) ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 166: 518–624.
[12]
Grocott MP, Martin DS, Levett DZ, McMorrow R, Windsor J, et al. (2009) Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med 360: 140–149.
[13]
Bloch KE, Latshang TD, Turk AJ, Hess T, Hefti U, et al. (2010) Nocturnal periodic breathing during acclimatization at very high altitude at Mount Muztagh Ata (7,546 m). Am J Respir Crit Care Med 182: 562–568.
[14]
Sackner MA, Watson H, Belsito AS, Feinerman D, Suarez M, et al. (1989) Calibration of respiratory inductive plethysmograph during natural breathing. J Appl Physiol 66: 410–420.
[15]
Vock P, Brutsche MH, Nanzer A, Bartsch P (1991) Variable radiomorphologic data of high altitude pulmonary edema. Features from 60 patients. Chest 100: 1306–1311.
[16]
Jaeger JJ, Sylvester JT, Cymerman A, Berberich JJ, Denniston JC, et al. (1979) Evidence for increased intrathoracic fluid volume in man at high altitude. J Appl Physiol 47: 670–676.
[17]
Mason NP, Petersen M, Melot C, Imanow B, Matveykine O, et al. (2003) Serial changes in nasal potential difference and lung electrical impedance tomography at high altitude. J Appl Physiol 94: 2043–2050.
[18]
Welsh CH, Wagner PD, Reeves JT, Lynch D, Cink TM, et al. (1993) Operation Everest. II: Spirometric and radiographic changes in acclimatized humans at simulated high altitudes. Am Rev Respir Dis 147: 1239–1244.
[19]
Deboeck G, Moraine JJ, Naeije R (2005) Respiratory muscle strength may explain hypoxia-induced decrease in vital capacity. Med Sci Sports Exerc 37: 754–758.
[20]
Miles DS, Doerr CE, Schonfeld SA, Sinks DE, Gotshall RW (1983) Changes in pulmonary diffusing capacity and closing volume after running a marathon. Respir Physiol 52: 349–359.
[21]
Roughton FJW, Forster RE (1957) Relative Importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J Appl Physiol 11: 290–302.
[22]
Ulrich S, Fischler M, Speich R, Bloch KE (2008) Sleep-related breathing disorders in patients with pulmonary hypertension. Chest 133: 1375–1380.
[23]
Brack T, Thuer I, Clarenbach CF, Senn O, Noll G, et al. (2007) Daytime Cheyne-Stokes respiration in ambulatory patients with severe congestive heart failure is associated with increased mortality. Chest 132: 1463–1471.
